Estee Lauder Companies Inc header image

Estee Lauder Companies Inc

EL

Equity

ISIN null / Valor 99350

New York Stock Exchange, Inc (2026-08-28)
USD 103.39-2.66%

Estee Lauder Companies Inc
UMushroom community rating:

star star star star star
4.15 5 votes No rating yet
NegativeNeutralPositive

About company

Estée Lauder Companies Inc. is a New York–based, publicly traded multinational beauty company that develops, manufactures and sells a broad portfolio of skincare, makeup, fragrance and hair-care products through a mix of wholesale and direct channels worldwide. Built around a collection of largely prestige and specialty brands — including names such as Estée Lauder, Clinique, M·A·C., La Mer, Jo Malone, Tom Ford Beauty, Le Labo and Aveda — the company distributes via department and specialty stores, travel retail, salons and its growing e-commerce operations, while also investing in product development, marketing and selective acquisitions to expand category reach and international footprint.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

12.7%1Y
-33.9%3Y
-69.7%5Y

Performance

49.4%1Y
49.5%3Y
45.2%5Y

Volatility

Market cap

25567 M

Market cap (USD)

Daily traded volume (Shares)

3,121,968

Daily traded volume (Shares)

1 day high/low

74.62 / 72.8

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

4.15

5 votes
Performance:
starstarstarstarstar
3.77
Innovation:
starstarstarstarstar
4.08
Society:
starstarstarstarstar
3.46
Nature:
starstarstarstarstar
3.69
Loic Aebischer
Switzerland, 16 Mar 2026
star star star star star
very nice
Sammy Siagos
UK, 24 Oct 2025
star star star star star
decent
Charles Davis
UK, 22 Oct 2025
star star star star star
Recent restructuring + focus on digital transformation

EQUITIES OF THE SAME SECTOR

agilon health inc
agilon health inc agilon health inc Valor: 110653729
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.74%USD 92.54
Laurus Labs Ltd.
Laurus Labs Ltd. Laurus Labs Ltd. Valor: 56464789
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.80%INR 1,935.30
Amphastar Pharmaceuticals Inc
Amphastar Pharmaceuticals Inc Amphastar Pharmaceuticals Inc Valor: 24511852
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.59%USD 22.01
NATCO Pharma Limited
NATCO Pharma Limited NATCO Pharma Limited Valor: 30461955
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.57%INR 853.35
Syndax Pharmaceuticals Inc
Syndax Pharmaceuticals Inc Syndax Pharmaceuticals Inc Valor: 24112479
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.08%USD 19.54
Healthcare Services Group Inc
Healthcare Services Group Inc Healthcare Services Group Inc Valor: 938239
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.18%USD 22.44
GE Healthcare Technologies Inc
GE Healthcare Technologies Inc GE Healthcare Technologies Inc Valor: 123735674
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.04%USD 71.72
Arvinas Inc
Arvinas Inc Arvinas Inc Valor: 43526042
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.65%USD 9.18
Roche Holding Ltd
Roche Holding Ltd Roche Holding Ltd Valor: 1203204
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.46%CHF 358.70
Straumann Holding Ltd
Straumann Holding Ltd Straumann Holding Ltd Valor: 117544866
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.11%CHF 93.20